A compound of formula (I) or a salt, ester or amide thereof; where X is O, or S, S(O) or S(O).sub.2 or NR.sup.10 where R.sup.10 is hydrogen or C.sub.1-6 alkyl, and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8 and R.sup.9 are various specified organic groups. These compounds are inhibitors of aurora 2 kinase, and are useful in the treatment of cancer. ##STR00001##
Claims The invention claimed is: 1. A compound of formula (I) ##STR00009## or a salt, or phosphate ester thereof; where X is O, or S, S(O) or S(O).sub.2 or NR.sup.10 where R.sup.10 is hydrogen or C.sub.1-6alkyl; R.sup.5 is a group OR.sup.11, NR.sup.12R.sup.13 or SR.sup.11 where R.sup.11, R.sup.12 and R.sup.13 are independently selected from hydrogen, optionally substituted hydrocarbyl where optional substituents are functional groups, or optionally substituted heterocyclic groups where optional substituents are functional groups or hydrocarbyl, and R.sup.12 and R.sup.13 may additionally form together with the nitrogen atom to which they are attached, an optionally substituted aromatic or non-aromatic heterocyclic ring which may contain further heteroatoms; R.sup.6 and R.sup.7 are independently selected from hydrogen or hydrocarbyl; R.sup.8 and R.sup.9 are independently selected from hydrogen, halo, C.sub.1-4alkyl, C.sub.1-4alkoxy, C.sub.1-4alkoxymethyl, di(C.sub.1-4alkoxy)methyl, C.sub.1-4alkanoyl, trifluoromethyl, cyano, amino, C.sub.2-5alkenyl, C.sub.2-5alkynyl, a phenyl group, a benzyl group or a 5 6-membered heterocyclic group with 1 3 heteroatoms selected independently from O, S and N, which heterocyclic group may be aromatic or non-aromatic and may be saturated, linked via a ring carbon or nitrogen atom, or unsaturated, linked via a ring carbon atom, and which phenyl, benzyl or heterocyclic group may bear on one or more ring carbon atoms up to 5 substituents selected from hydroxy, halogeno, C.sub.1-3alkyl, C.sub.1-3alkoxy, C.sub.1-3alkanoyloxy, trifluoromethyl, cyano, amino, nitro, C.sub.2-4alkanoyl, C.sub.1-4alkanoylamino, C.sub.1-4alkoxycarbonyl, C.sub.1-4alkylsulphanyl, C.sub.1-4alkylsulphinyl, C.sub.1-4alkylsulphonyl, carbamoyl, N-C.sub.1-4alkylcarbamoyl, N,N-di(C.sub.1-4alkyl)carbamoyl, aminosulphonyl, N-C.sub.1-4alkylaminosulphonyl, N,N-di(C.sub.1-4alkyl)aminosulphonyl, C.sub.1-4alkylsulphonylamino, and a saturated heterocyclic group selected from morpholino, thiomorpholino, pyrrolidinyl, piperazinyl, piperidinyl imidazolidinyl and pyrazolidinyl, which saturated heterocyclic group may bear 1 or 2 substituents selected from oxo, hydroxy, halogeno, C.sub.1-3alkyl, C.sub.1-3alkoxy, C.sub.1-3alkanoyloxy, trifluoromethyl, cyano, amino, nitro and C.sub.1-4alkoxycarbonyl; and R.sup.1, R.sup.2, R.sup.3, R.sup.4 are independently selected from halogeno, cyano, nitro, C.sub.1-3alkylsulphanyl, --N(OH)R.sup.14 wherein R.sup.14 is hydrogen or C.sub.1-3alkyl, or R.sup.16X.sup.1-- wherein X.sup.1 represents a direct bond, --O--, --CH.sub.2--, --OC(O)--, --C(O)--, --S--, --SO--, --SO.sub.2--, --NR.sup.17C(O)--, --C(O)NR.sup.18--, --SO.sub.2NR.sup.19--, --NR.sup.20SO.sub.2-- or --NR.sup.21--, wherein R.sup.17, R.sup.18, R.sup.19, R.sup.20 and R.sup.21 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and R.sup.16 is selected from one of the following twenty-two groups; 1) hydrogen or C.sub.1-5alkyl which may be unsubstituted or which may be substituted with one or more groups selected from hydroxy, oxiranyl, fluoro, chloro, bromo, amino, C.sub.1-3alkyl, and trifluoromethyl; 2) --R.sup.3X.sup.2C(O)R.sup.22; wherein X.sup.2 represents --O-- or --NR.sup.23--, in which R.sup.23 represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl) and R.sup.22 represents C.sub.1-3alkyl, --NR.sup.24R.sup.25 or --OR.sup.26, wherein R.sup.24, R.sup.25 and R.sup.26 which may be the same or different each represents hydrogen, C.sub.1-5alkyl, hydroxyC.sub.1-5alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl; 3) --R.sup.bX.sup.3R.sup.27; wherein X.sup.3 represents --O--, C(O)--S--, --SO--, --SO.sub.2--, --OC(O)--, --NR.sup.28C(O)--, --NR.sup.28C(O)O--, --C(O)NR.sup.29--, C(O)ONR.sup.29--, --SO.sub.2NR.sup.30--, --NR.sup.31SO.sub.2-- or 'NR.sup.32--, wherein R.sup.28, R.sup.29, R.sup.30, R.sup.31 and R.sup.32 each independently represents hydrogen, C.sub.1-3alkyl, hydroxy C.sub.1-4alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and R.sup.27 represents hydrogen, C.sub.1-6alkyl, C.sub.2-6alkenyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, phenyl or a 5 6-membered saturated heterocyclic group with 1 2 heteroatoms, selected independently from O, S and N, which C.sub.1-6alkyl group may bear 1, 2 or 3 substituents selected from oxo, hydroxy, halogeno, cyclopropyl, amino, C.sub.1-4alkylamino, C.sub.1-4alkanoyldi-C.sub.1-4alkylamino, C.sub.1-4alkylthio, C.sub.1-4alkoxy and which cyclic group may bear 1 or 2 substituents selected from oxo, hydroxy, halogeno, cyano, C.sub.1-4cyanoalkyl, C.sub.1-4alkyl, C.sub.1-4hydroxyalkyl, C.sub.1-4alkoxy, C.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.1-4alkylsulphonylC.sub.1-4alkyl, C.sub.1-4alkoxycarbonyl, C.sub.1-4aminoalkyl, C.sub.1-4alkylamino di(C.sub.1-4alkyl)amino, C.sub.1-4alkylaminoC.sub.1-4alkyl, di(C.sub.1-4alkyl)aminoC.sub.1-4alkyl, C.sub.1-4alkylaminoC.sub.1-4alkoxy, di(C.sub.1-4alkyl)aminoC.sub.1-4alkoxy and a group --(--O--).sub.f(R.sup.b').sub.gD, wherein f is 0 or 1, q is 0 or 1 and D is a cyclic group selected from C.sub.3-6cycloalkyl group, an aryl group or a 5 6-membered saturated or unsaturated heterocyclic group with 1 2 heteroatoms, selected independently from O, S and N, which cyclic group may bear one or more substituents selected from halo or C.sub.1-4alkyl; 4) --R.sup.cX.sup.4R.sup.c'X.sup.5R.sup.35; wherein X.sup.4 and X.sup.5 which may be the same or different are each --O--, C(O), --S--, --SO--, --SO.sub.2--, --NR.sup.36C(O)--, --NR.sup.36C(O)O--, --C(O)NR.sup.37--, --C(O)ONR.sup.37--, --SO.sub.2NR.sup.38--, --NR.sup.39SO.sub.2-- or --NR.sup.40--, wherein R.sup.36, R.sup.37, R.sup.38, R.sup.39 and R.sup.40 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and R.sup.35 represents hydrogen, C.sub.1-3alkyl, hydroxyC.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl; 5) R.sup.41; wherein R.sup.41 is a 4 6-membered cycloalkyl or saturated heterocyclic ring, linked via carbon or nitrogen, with 1 2 heteroatoms, selected independently form O, S and N, which cycloalkyl or heterocyclic group may bear 1 or 2 substituents selected from oxo, hydroxy, halogeno, cyano, C.sub.1-4alkyl, hydroxyC.sub.1-4alkyl, cyanoC.sub.1-4alkyl, cyclopropyl, C.sub.1-4alkylsulphonylC.sub.1-4alkyl, C.sub.1-4alkoxycarbonyl, carboxamido, C.sub.1-4aminoalkyl, C.sub.1-4alkylamino, di(C.sub.1-4alkyl)amino, C.sub.1-4alkylaminoC.sub.1-4alkyl, C.sub.1-4alkanoyl, di(C.sub.1-4alkyl)aminoC.sub.1-4alkyl, C.sub.1-4alkylaminoC.sub.1-4alkoxy, di(C.sub.1-4alkyl)aminoC.sub.1-4alkoxy nitro, amino, C.sub.1-4alkoxy, C.sub.1-4hydroxyalkoxy, carboxy, trifluoromethyl, --C(O)NR.sup.43R.sup.44, --NR.sup.45C(O)R.sup.46, wherein R.sup.43, R.sup.44, R.sup.45 and R.sup.46, which may be the same or different, each represents hydrogen, C.sub.1-4alkyl, hydroxyC.sub.1-4alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl) and a group --(--O--).sub.f(C.sub.1-4alkyl).sub.gringD, wherein f is 0 or 1, g is 0 or 1 and D is a cyclic group selected from C.sub.3-6cycloalkyl, aryl or 5 6-membered saturated or unsaturated heterocyclic group with 1 2 heteroatoms, selected independently from O, S and N, which cyclic group may bear one or more substituents selected from halo and C.sub.1-4alkyl; 6) --R.sup.dR.sup.41; wherein R.sup.41 is as defined hereinbefore; 7) --R.sup.eR.sup.41; wherein R.sup.41 is as defined hereinbefore; 8) --R.sup.fR.sup.41; wherein R.sup.41 is as defined hereinbefore; 9) R.sup.42; wherein R.sup.42 represents a phenyl group or a 5 6-membered aromatic heterocyclic group, linked via carbon or nitrogen, with 1 3 heteroatoms selected from O, N and S, which phenyl or aromatic heterocyclic group may carry up to 5 substituents selected from hydroxy, nitro, halogeno, amino, C.sub.1-4alkyl, C.sub.1-4alkoxy, C.sub.1-4hydroxyalkyl, C.sub.1-4aminoalkyl, C.sub.1-4alkylamino, C.sub.1-4hydroxyalkoxy, oxo, cyanoC.sub.1-4alkyl, cyclopropyl, C.sub.1-4alkylsulphonylC.sub.1-4alkyl, C.sub.1-4alkoxycarbonyl, di(C.sub.1-4alkyl)amino, C.sub.1-4alkylaminoC.sub.1-4alkyl, C.sub.1-4alkanoyl, di(C.sub.1-4alkyl)aminoC.sub.1-4alkyl, C.sub.1-4alkylaminoC.sub.1-4alkoxy, di(C.sub.1-4alkyl)aminoC.sub.1-4alkoxy, carboxy, carboxamido, trifluoromethyl, cyano, --C(O)NR.sup.69R.sup.70, --NR.sup.71C(O)R.sup.72, wherein R.sup.69, R.sup.70, R.sup.71 and R.sup.72, which may be the same or different, each represents hydrogen, C.sub.1-4alkyl, hydroxyC.sub.1-4alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and a group --(--O--).sub.f(C.sub.1-4alkyl).sub.gringD, wherein f is 0 or 1, g is 0 or 1 and ring D is a cyclic group selected from C.sub.3-6cycloalkyl, aryl or 5 6-membered saturated or unsaturated heterocyclic group with 1 2 heteroatoms, selected independently from O, S and N, which cyclic group may bear one or more substituents selected from halo and C.sub.1-4alkyl; 10) --R.sup.gR.sup.42; wherein R.sup.42 is as defined hereinbefore; 11) --R.sup.hR.sup.42; wherein R.sup.42 is as defined hereinbefore; 12) --R.sup.iR.sup.42; wherein R.sup.42 is as defined hereinbefore; 13) --R.sup.jX.sup.6R.sup.42; wherein X.sup.6 represents --O--, --C(O)--, --S--, --SO--, --SO.sub.2--, --OC(O)--, --NR.sup.47C(O)--, --C(O)NR.sup.48--, C(O)ONR.sup.48--, --SO.sub.2NR.sup.49--, --NR.sup.50SO.sub.2-- or --NR.sup.51--, wherein R.sup.47, R.sup.48, R.sup.49, R.sup.50 and R.sup.51 each independently represents hydrogen, C.sub.1-3alkyl, hydroxyC.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and R.sup.42 is as defined hereinbefore; 14) --R.sup.kX.sup.7R.sup.42; wherein X.sup.7 represents --O--, C(O), --S--, --SO--, --SO.sub.2--, --NR.sup.73C(O)--, --C(O)NR.sup.74--, C(O)ONR.sup.74--, --SO.sub.2NR.sup.75--, --NR.sup.76SO.sub.2-- or --NR.sup.77--, wherein R.sup.73, R.sup.74, R.sup.75, R.sup.76 and R.sup.77 each independently represents hydrogen, C.sub.1-3alkyl, hydroxyC.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and R.sup.42 is as defined hereinbefore; 15) --R.sup.mX.sup.8R.sup.42; wherein X.sup.8 represents --O--, --(CO)--, --S--, --SO--, --SO.sub.2--, --NR.sup.57C(O)--, --C(O)NR.sup.58--, --SO.sub.2NR.sup.59--, --NR.sup.60SO.sub.2-- or --NR.sup.61--, wherein R.sup.57, R.sup.58, R.sup.59, R.sup.60 and R.sup.61 each independently represents hydrogen, C.sub.1-3alkyl, hydroxyC.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and R.sup.42 is as defined hereinbefore; 16) --R.sup.nX.sup.9R.sup.n'R.sup.42; wherein X.sup.9 represents --O--, --C(O)--, --S--, --SO--, --SO.sub.2--, --NR.sup.62C(O)--, --C(O)NR.sup.63--, C(O)ONR.sup.63--, --SO.sub.2NR.sup.64--, --NR.sup.65SO.sub.2-- or --NR.sup.66--, wherein R.sup.62, R.sup.63, R.sup.64, R.sup.65 and R.sup.66 each independently represents hydrogen, C.sub.1-3alkyl, hydroxyC.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and R.sup.42 is as defined hereinbefore; 17) --R.sup.pX.sup.9--R.sup.p'1R.sup.41; wherein X.sup.9 and R.sup.41 are as defined hereinbefore; 18) C.sub.2-5alkenyl which may be unsubstituted or which may be substituted with one or more groups selected from hydroxy, fluoro, amino, C.sub.1-4alkylamino, N,N-di(C.sub.1-4alkyl)amino, aminosulphonyl, N-C.sub.1-4alkylaminosulphonyl and N,N-di(C.sub.1-4alkyl)aminosulphonyl; 19) C.sub.2-5alkynyl which may be unsubstituted or which may be substituted with one or more groups selected from hydroxy, fluoro, amino, C.sub.1-4alkylamino, N,N-di(C.sub.1-4alkyl)amino, aminosulphonyl, N-C.sub.1-4alkylaminosulphonyl and N,N-di(C.sub.1-4alkyl)aminosulphonyl; 20) --R.sup.tX.sup.9R.sup.t'R.sup.41; wherein X.sup.9 and R.sup.41 are as defined hereinbefore; 21) --R.sup.uX.sup.9R.sup.u'R.sup.41; wherein X.sup.9 and R.sup.41 are as defined hereinbefore; and 22) --R.sup.vR.sup.67(R.sup.v').sub.q(X.sup.9).sub.rR.sup.68; wherein X.sup.9 is as defined hereinbefore, q is 0 or 1, r is 0 or 1, and R.sup.67 is a C.sub.1-3alkylene group or a cyclic group selected from cyclopropyl, cyclobutyl, cyclopentylene, cyclohexylene or a 5 6-membered saturated heterocyclic group with 1 2 heteroatoms, selected independently from O, S and N, which C.sub.1-3alkylene group may bear 1 or 2 substituents selected from oxo, hydroxy, halogeno and C.sub.1-4alkoxy and which cyclic group may bear 1 or 2 substituents selected from oxo, hydroxy, halogeno, cyano, C.sub.1-4cyanoalkyl, C.sub.1-4alkyl, C.sub.1-4hydroxyalkyl, C.sub.1-4alkoxy, C.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.1-4alkylsulphonylC.sub.1-4alkyl, C.sub.1-4alkoxycarbonyl, C.sub.1-4aminoalkyl, C.sub.1-4alkylamino, di(C.sub.1-4alkyl)amino, C.sub.1-4alkylaminoC.sub.1-4alkyl, di(C.sub.1-4alkyl)aminoC.sub.1-4alkyl, C.sub.1-4alkylaminoC.sub.1-4alkoxy, di(C.sub.1-4alkyl)aminoC.sub.1-4alkoxy and a group --(--O--).sub.f(C.sub.1-4alkyl).sub.gringD, wherein f is 0 or 1, g is 0 or 1 and ring D is a cyclic group selected from C.sub.3-6cycloalkyl, aryl or 5 6-membered saturated or unsaturated heterocyclic group with 1 2 heteroatoms, selected independently from O, S and N, which cyclic group may bear one or more substituents selected from halo and C.sub.1-4alkyl; and R.sup.68 is hydrogen, C.sub.1-3alkyl, or a cyclic group selected from cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and a 5 6-membered saturated heterocyclic group with 1 2 heteroatoms, selected independently from O, S and N, which C.sub.1-3alkyl group may bear 1 or 2 substituents selected from oxo, hydroxy, halogeno, C.sub.1-4alkoxy and which cyclic group may bear 1 or 2 substituents selected from oxo, hydroxy, halogeno, cyano, C.sub.1-4cyanoalkyl, C.sub.1-4alkyl, C.sub.1-4hydroxyalkyl, C.sub.1-4alkoxy, C.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.1-4alkylsulphonylC.sub.1-4alkyl, C.sub.1-4alkoxycarbonyl, C.sub.1-4aminoalkyl, C.sub.1-4alkylamino, di(C.sub.1-4alkyl)amino, C.sub.1-4alkylaminoC.sub.1-4alkyl, di(C.sub.1-4alkyl)aminoC.sub.1-4alkyl, C.sub.1-4alkylaminoC.sub.1-4alkoxy, di(C.sub.1-4alkyl)aminoC.sub.1-4alkoxy and a group --(--O--).sub.f(C.sub.1-4alkyl).sub.gringD, wherein f is 0 or 1, g is 0 or 1 and ring D is a cyclic group selected from C.sub.3-6cycloalkyl, aryl or 5 6-membered saturated or unsaturated heterocyclic group with 1 2 heteroatoms, selected independently from O, S and N, which cyclic group may bear one or more substituents selected from halo and C.sub.1-4alkyl; and wherein R.sup.a, R.sup.b, R.sup.b', R.sup.c, R.sup.c', R.sup.d, R.sup.g, R.sup.j, R.sup.n, R.sup.n', R.sup.p, R.sup.p', R.sup.t', R.sup.u', R.sup.v and R.sup.v' are independently selected from C.sub.1-8alkylene groups optionally substituted by one or more substituents selected from hydroxy, halogeno, amino, R.sup.e R.sup.h, R.sup.k and R.sup.t are independently selected from C.sub.2-8alkenylene groups optionally substituted by one or more substituents selected from hydroxy, halogeno, amino, and R.sup.t may additionally be a bond; and R.sup.f, R.sup.i, R.sup.m and R.sup.u are independently selected from by C.sub.2-8alkynylene groups optionally substituted by one or more substituents selected from hydroxy, halogeno, amino; wherein a phosphate ester is a derivative of a hydroxy group present on one or more of R.sup.1, R.sup.2, R.sup.3 or R.sup.4; wherein functional group refers to reactive substituents selected from nitro, cyano, halo, oxo, .dbd.CR.sup.78R.sup.79, C(O).sub.xR.sup.77, OR.sup.77, S(O).sub.yR.sup.77, NR.sup.78R.sup.79, C(O)NR.sup.78R.sup.79, OC(O)NR.sup.78R.sup.79, .dbd.NOR.sup.77, --NR.sup.77C(O).sub.xR.sup.78, --NR.sup.77CONR.sup.78R.sup.79, --N.dbd.CR.sup.78R.sup.79, S(O).sub.yNR.sup.78R.sup.79 or --NR.sup.77S(O).sub.yR.sup.78 where R.sup.77, R.sup.78 and R.sup.79 are independently selected from hydrogen, optionally substituted hydrocarbyl, optionally substituted heterocyclyl or optionally substituted C.sub.1-10alkoxy, or R.sup.78 and R.sup.79 together form an optionally substituted ring which optionally contains further heteroatoms such as oxygen, nitrogen, S, S(O) or S(O).sub.2, where x is an integer of 1 or 2, y is 0 or an integer of 1 3; and where optional substituents for hydrocarbyl, heterocyclyl or C.sub.1-10alkoxy groups R.sup.77, R.sup.78 and R.sup.79 as well as rings formed by R.sup.78 and R.sup.79 are halo, perhaloC.sub.1-10alkyl, mercapto, thioC.sub.1-10alkyl, hydroxy, carboxy, C.sub.1-10alkoxy, heteroaryl, heteroaryloxy, C.sub.3-10cycloalkyl, C.sub.3-10cycloalkenyl, C.sub.3-10cycloalkynyl, C.sub.2-10alkenyloxy, C.sub.2-10alkynyloxy, C.sub.1-10alkoxyC.sub.1-10alkoxy, aryloxy where the aryl group may be substituted by halo, nitro or hydroxy, cyano, nitro, amino, mono- or di-C.sub.1-10alkyl amino, oximino or S(O).sub.yR.sup.90 where y is as defined above and R.sup.90 is a C.sub.1-10alkyl; and wherein hydrocarbyl is selected from C.sub.1-10alkyl, C.sub.2-10alkenyl, C.sub.2-10alkynyl, aryl, arC.sub.1-10alkyl, C.sub.3-10cycloalkyl, C.sub.3-10cycloalkenyl or C.sub.3-10cycloalkynyl; or C.sub.1-10alkyl, C.sub.2-10alkenyl or C.sub.2-10alkynyl substituted with aryl, arC.sub.1-10alkyl, C.sub.3-10cycloalkyl, C.sub.3-10cycloalkenyl or C.sub.3-10cycloalkynyl; or an aryl, heterocyclyl, C.sub.1-10alkoxy, arC.sub.1-10alkyl, C.sub.3-10cycloalkyl, C.sub.3-10cycloalkenyl or C.sub.3-10cycloalkynyl substituted with C.sub.1-10alkyl, C.sub.2-10alkenyl, C.sub.2-10alkynyl or C.sub.1-10alkoxy. 2. A compound according to claim 1, or a salt, or phosphate ester thereof; wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 are independently selected from, halo, cyano, nitro, trifluoromethyl, C.sub.1-3alkyl, --NR.sup.14R.sup.15, wherein R.sup.14 and R.sup.15, which may be the same or different, each represents hydrogen or C.sub.1-3alkyl, or --X.sup.1R.sup.16, wherein X.sup.1 represents a direct bond, --O--, --CH.sub.2--, --OCO--, carbonyl, --S--, --SO--, --SO.sub.2--, --NR.sup.17CO--, --CONR.sup.18--, --SO.sub.2NR.sup.19--, --NR.sup.20SO.sub.2-- or --NR.sup.21--, wherein R.sup.17, R.sup.18, R.sup.19, R.sup.20 and R.sup.21 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and R.sup.16 is selected from one of the following seventeen groups: 1') hydrogen or C.sub.1-5alkyl which may be unsubstituted or which may be substituted with one or more groups selected from hydroxy, fluoro or amino; 2') C.sub.1-5alkylX.sup.2COR.sup.22; wherein X.sup.2 represents --O-- or --NR.sup.23-- in which R.sup.23 represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl and R.sup.22 represents C.sub.1-3alkyl, --NR.sup.24R.sup.25 or --OR.sup.26, wherein R.sup.24, R.sup.25 and R.sup.26 which may be the same or different each represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl; 3') C.sub.1-5alkylX.sup.3R.sup.27; wherein X.sup.3 represents --O--, --S--, --SO--, --SO.sub.2--, --OCO--, --NR.sup.28CO--, --CONR.sup.29--, --SO.sub.2NR.sup.30--, --NR.sup.31SO.sub.2-- or --NR.sup.32--, wherein R.sup.28, R.sup.29, R.sup.30, R.sup.31 and R.sup.32 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and R.sup.27 represents hydrogen, C.sub.1-3alkyl, cyclopentyl, cyclohexyl or a 5 6-membered saturated heterocyclic group with 1 2 heteroatoms selected independently from O, S and N, which C.sub.1-3alkyl group may bear 1 or 2 substituents selected from oxo, hydroxy, halogeno and C.sub.1-4alkoxy and which cyclic group may bear 1 or 2 substituents selected from oxo, hydroxy, halogeno, C.sub.1-4alkyl, C.sub.1-4hydroxyalkyl and C.sub.1-4alkoxy; 4') C.sub.1-5-alkylX.sup.4C.sub.1-5alkylX.sup.5R.sup.35; wherein X.sup.4 and X.sup.5 which may be the same or different are each --O--, --S--, --SO--, --SO.sub.2--, --NR.sup.36CO--, --CONR.sup.37--, --SO.sub.2NR.sup.38--, --NR.sup.39SO.sub.2-- or --NR.sup.40--, wherein R.sup.36, R.sup.37, R.sup.38, R.sup.39 and R.sup.40 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and R.sup.35 represents hydrogen or C.sub.1-3alkyl; 5') R.sup.41; wherein R.sup.41 is a 5 6-membered saturated heterocyclic group, linked via carbon or nitrogen, with 1 2 heteroatoms selected independently from O, S and N, which heterocyclic group may bear 1 or 2 substituents selected from oxo, hydroxy, halogeno, C.sub.1-4alkyl, C.sub.1-4hydroxyalkyl, C.sub.1-4alkoxy, C.sub.1-4alkoxyC.sub.1-4alkyl and C.sub.1-4alkylsulphonylC.sub.1-4alkyl; 6') C.sub.1-5alkylR.sup.41; wherein R.sup.41 is as defined hereinbefore; 7') C.sub.2-5alkenylR.sup.41; wherein R.sup.41 is as defined hereinbefore; 8') C.sub.2-5alkynylR.sup.41; wherein R.sup.41 is as defined hereinbefore; 9') R.sup.42; wherein R.sup.42 represents a phenyl group or a 5 6-membered aromatic heterocyclic group, linked via carbon or nitrogen, with 1 3 heteroatoms selected from O, N and S, which phenyl or aromatic heterocyclic group may carry up to 5 substituents on an available carbon atom selected from hydroxy, halogeno, amino, C.sub.1-4alkyl, C.sub.1-4alkoxy, C.sub.1-4hydroxyalkyl, C.sub.1-4aminoalkyl, C.sub.1-4alkylamino, C.sub.1-4hydroxyalkoxy, carboxy, trifluoromethyl, cyano, --CONR.sup.43R.sup.44 and --NR.sup.45COR.sup.46, wherein R.sup.43, R.sup.44, R.sup.45 and R.sup.46, which may be the same or different, each represents hydrogen, C.sub.1-4alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl; 10') C.sub.1-5alkylR.sup.42; wherein R.sup.42 is as defined hereinbefore; 11') C.sub.2-5alkenylR.sup.42; wherein R.sup.42 is as defined hereinbefore; 12') C.sub.2-5alkynylR.sup.42; wherein R.sup.42 is as defined hereinbefore; 13') C.sub.1-5alkylX.sup.6R.sup.42; wherein X.sup.6 represents --O--, --S--, --SO--, --SO.sub.2--, --NR.sup.47CO--, --CONR.sup.48--, --SO.sub.2NR.sup.49--, --NR.sup.50SO.sub.2-- or --NR.sup.51--, wherein R.sup.47, R.sup.48, R.sup.49, R.sup.50 and R.sup.51 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and R.sup.42 is as defined hereinbefore; 14') C.sub.2-5alkenylX.sup.7R.sup.42; wherein X.sup.7 represents --O--, --S--, --SO--, --SO.sub.2--, --NR.sup.52CO--, --CONR.sup.53--, --SO.sub.2NR.sup.54--, --NR.sup.55SO.sub.2-- or --NR.sup.56--, wherein R.sup.52, R.sup.53, R.sup.54, R.sup.55 and R.sup.56 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and R.sup.42 is as defined hereinbefore; 15') C.sub.2-5alkynylX.sup.8R.sup.42; wherein X.sup.8 represents --O--, --S--, --SO--, --SO.sub.2--, --NR.sup.57CO--, --CONR.sup.58--, --SO.sub.2NR.sup.59--, --NR.sup.60SO.sub.2-- or --NR.sup.61--, wherein R.sup.57, R.sup.58, R.sup.59, R.sup.60 and R.sup.61 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and R.sup.42 is as defined hereinbefore; 16') C.sub.1-3alkylX.sup.9C.sub.1-3alkylR.sup.42; wherein X.sup.9 represents --O--, --S--, --SO--, --SO.sub.2--, --NR.sup.62CO--, --CONR.sup.63--, --SO.sub.2NR.sup.64--, --NR.sup.65SO.sub.2-- or --NR.sup.66--, wherein R.sup.62, R.sup.63, R.sup.64, R.sup.65 and R.sup.66 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and R.sup.42 is as defined hereinbefore; and 17') C.sub.1-3alkylX.sup.9C.sub.1-3alkylR.sup.41; wherein X.sup.9 and R.sup.41 are as defined hereinbefore; and R.sup.6 and R.sup.7 are hydrogen or C.sub.1-4alkyl. 3. A compound according to claim 2, or a salt or phosphate ester, thereof wherein R.sup.6 and R.sup.7 are hydrogen. 4. A compound according to claim 1 or a salt or phosphate ester thereof, wherein R.sup.5 is selected from a group OR.sup.11 where R.sup.11 is hydrogen or C.sub.1-4alkyl; or a group NR.sup.12R.sup.13 where one of R.sup.12 or R.sup.13 is hydrogen and the other is optionally substituted C.sub.1-6alkyl, optionally substituted aryl or optionally substituted heterocyclyl, or R.sup.12 and R.sup.13 together with the nitrogen atom to which they are attached form a heterocyclic ring. 5. A compound according to claim 4, which is a phosphate ester of a compound of formula (I). 6. A compound according to claim 4, or a salt or phosphate ester thereof; where R.sup.5 is a group OR.sup.11, NR.sup.12R.sup.13 or SR.sup.11 where R.sup.11 is hydrogen or C.sub.1-4alkyl, and where one of R.sup.12 and R.sup.13 is hydrogen and the other is C.sub.1-6alkyl optionally substituted with one or more groups selected from hydroxy, trifluoromethyl, C.sub.1-3alkoxy, cyano, amino, mono- or di-C.sub.1-4alkylamino, C.sub.1-4alkylthio, C.sub.3-6cycloalkyl or heterocyclyl optionally substituted with C.sub.1-4alkyl; or one of R.sup.12 and R.sup.13 is hydrogen and the other is a heterocyclic group as well as dioxides thereof, C.sub.3-6cycloalkyl or a phenyl group any of which may be substituted with one or more groups selected from halo, nitro, C.sub.1-4alkyl or C.sub.1-4alkoxy, and R.sup.12 and R.sup.13 may additionally form together with the nitrogen atom to which they are attached, morpholine or piperidine; R.sup.6 and R.sup.7 are independently selected from hydrogen or C.sub.1-4alkyl; R.sup.8 and R.sup.9 are independently selected from hydrogen, halo, C.sub.1-4alkoxy, trifluoromethyl, cyano or phenyl. 7. A compound according to claim 6, or a salt or phosphate ester thereof, wherein X is NH or O. 8. A compound according to claim 6, or a salt or phosphate ester thereof, wherein R.sup.1 is hydrogen; R.sup.2 is halo, cyano, nitro, trifluoromethyl, C.sub.1-3alkyl, --NR.sup.14R.sup.15, wherein R.sup.14 and R.sup.15, which may be the same or different, each represents hydrogen or C.sub.1-3alkyl, or a group --X.sup.1R.sup.16 where X.sup.1 is oxygen and R.sup.16 is a group (1); R.sup.3 is a group --X.sup.1R.sup.16 where X.sup.1 is oxygen and R.sup.16 is a group selected from group (1), (3), (6) and (10); and R.sup.4 is hydrogen, halo, C.sub.1-4alkyl, or C.sub.1-4alkoxy; wherein group (1) is hydrogen or C.sub.1-5alkyl which may be unsubstituted or which may be substituted with one or more groups selected from hydroxy, oxiranyl, fluoro, chloro, bromo, amino, C.sub.1-3alkyl and trifluoromethyl; group (3) is --R.sup.bX.sup.3R.sup.27; wherein X.sup.3 represents --O--, C(O)--S--, --SO--, --SO.sub.2--, --OC(O)--, --NR.sup.28C(O)--, --NR.sup.28C(O)O--, --C(O)NR.sup.29--, C(O)ONR.sup.29--, --SO.sub.2NR.sup.30--, --NR.sup.31SO.sub.2-- or --NR.sup.32-- wherein R.sup.28, R.sup.29, R.sup.30, R.sup.31 and R.sup.32 each independently represents hydrogen, C.sub.1-3alkyl, hydroxy C.sub.1-4alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and R.sup.27 represents hydrogen, C.sub.1-6alkyl, C.sub.2-6alkenyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, phenyl or a 5 6-membered saturated heterocyclic group with 1 2 heteroatoms, selected independently from O, S and N, which C.sub.1-6alkyl group may bear 1, 2 or 3 substituents selected from oxo, hydroxy, halogeno, cyclopropyl, amino, C.sub.1-4alkylamino, C.sub.1-4alkanoyldi-C.sub.1-4alkylamino, C.sub.1-4alkylthio, C.sub.1-4alkoxy and which cyclic group may bear 1 or 2 substituents selected from oxo, hydroxy, halogeno, cyano, C.sub.1-4cyanoalkyl, C.sub.1-4alkyl, C.sub.1-4hydroxyalkyl, C.sub.1-4alkoxy, C.sub.1-4alkoxyC.sub.1-4alkyl, C.sub.1-4alkylsulphonylC.sub.1-4alkyl, C.sub.1-4alkoxycarbonyl, C.sub.1-4aminoalkyl, C.sub.1-4alkylamino, di(C.sub.1-4alkyl)amino, C.sub.1-4alkylaminoC.sub.1-4alkyl, di(C.sub.1-4alkyl)aminoC.sub.1-4alkyl, C.sub.1-4alkylaminoC.sub.1-4alkoxy, di(C.sub.1-4alkyl)aminoC.sub.1-4alkoxy and a group --(--O--).sub.f(R.sup.b').sub.gD, wherein f is 0 or 1, q is 0 or 1 and D is a cyclic group selected from C.sub.3-6cycloalkyl group, an aryl group or a 5 6-membered saturated or unsaturated heterocyclic group with 1 2 heteroatoms selected independently from O, S and N, which cyclic group may bear one or more substituents selected from halo or C.sub.1-4alkyl; group (6) is --R.sup.dR.sup.41; wherein R.sup.41 is a 4 6-membered cycloalkyl or saturated heterocyclic ring, linked via carbon or nitrogen with 1 2 heteroatoms selected independently from O, S and N, which cycloalkyl or heterocyclic group may bear 1 or 2 substituents selected from oxo, hydroxy, halogeno, cyano, C.sub.1-4alkyl, hydroxyC.sub.1-4alkyl, cyanoC.sub.1-4alkyl, cyclopropyl, C.sub.1-4alkylsulphonylC.sub.1-4alkyl, C.sub.1-4alkoxycarbonyl, carboxamido, C.sub.1-4aminoalkyl, C.sub.1-4alkylamino, di(C.sub.1-4alkyl)amino, C.sub.1-4alkylaminoC.sub.1-4alkyl, C.sub.1-4alkanoyl, di(C.sub.1-4alkyl)aminoC.sub.1-4alkyl, C.sub.1-4alkylaminoC.sub.1-4alkoxy, di(C.sub.1-4alkyl)aminoC.sub.1-4alkoxy nitro, amino, C.sub.1-4alkoxy, C.sub.1-4hydroxyalkoxy, carboxy, trifluoromethyl, --C(O)NR.sup.43R.sup.44, --NR.sup.45C(O)R.sup.46 wherein R.sup.43, R.sup.44, R.sup.45 and R.sup.46 which may be the same or different, each represents hydrogen, C.sub.1-4alkyl, hydroxyC.sub.1-4alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and a group --(--O--).sub.f(C.sub.1-4alkyl).sub.gringD, wherein f is 0 or 1, g is 0 or 1 and D is a cyclic group selected from C.sub.3-6cycloalkyl, aryl or 5 6-membered saturated or unsaturated heterocyclic group with 1 2 heteroatoms, selected independently from O, S and N, which cyclic group may bear one or more substituents selected from halo and C.sub.1-4alkyl; group (10) is --R.sup.gR.sup.42 wherein R.sup.42 represents a phenyl group or a 5 6-membered aromatic heterocyclic group, linked via carbon or nitrogen, with 1 3 heteroatoms selected from O, N and S, which phenyl or aromatic heterocyclic group may carry up to 5 substituents selected from hydroxy, nitro, halogeno, amino, C.sub.1-4alkyl, C.sub.1-4alkoxy, C.sub.1-4hydroxyalkyl, C.sub.1-4aminoalkyl, C.sub.1-4alkylamino, C.sub.1-4hydroxyalkoxy, oxo, cyanoC.sub.1-4alkyl, cyclopropyl, C.sub.1-4alkylsulphonylC.sub.1-4alkyl, C.sub.1-4alkoxycarbonyl, di(C.sub.1-4alkyl)amino, C.sub.1-4alkylaminoC.sub.1-4alkyl, C.sub.1-4alkanoyl, di(C.sub.1-4alkyl)aminoC.sub.1-4alkyl, C.sub.1-4alkylaminoC.sub.1-4alkoxy, di(C.sub.1-4alkyl)aminoC.sub.1-4alkoxy, carboxy, carboxamido, trifluoromethyl, cyano, --C(O)NR.sup.69R.sup.70, --NR.sup.71C(O)R.sup.72, wherein R.sup.69, R.sup.70, R.sup.71 and R.sup.72, which may be the same or different, each represents hydrogen, C.sub.1-4alkyl, hydroxyC.sub.1-4alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl, and a group --(--O--).sub.f(C.sub.1-4alkyl).sub.gringD wherein f is 0 or 1, g is 0 or 1 and ring D is a cyclic group selected from C.sub.3-6cycloalkyl, aryl or 5 6-membered saturated or unsaturated heterocyclic group with 1 2 heteroatoms selected independently from O, S and N, which cyclic group may bear one or more substituents selected from halo and C.sub.1-4alkyl; and R.sup.b, R.sup.b', R.sup.d and R.sup.g are independently selected from C.sub.1-6alkylene groups optionally substituted by one or more substituents selected from hydroxy, halogeno, amino. 9. A compound according to claim 6, or a salt or phosphate ester thereof, wherein R.sup.2 and R.sup.3 are independently methoxy or 3,3,3-trifluoroethoxy. 10. A compound according to claim 6, or a salt or phosphate ester thereof, wherein R.sup.3 is 3-morpholinopropoxy. 11. A compound according to claim 6, or a salt or phosphate ester thereof, wherein R.sup.8 and R.sup.9 are both hydrogen. 12. A compound according to claim 6, or a salt or phosphate ester thereof, wherein R.sup.6 and R.sup.7 are both hydrogen. 13. A compound according to claim 1 or a salt or phosphate ester thereof wherein X is NH or O. 14. A compound according to claim 1 or a salt or phosphate ester thereof wherein R.sup.6 and R.sup.7 are independently hydrogen or C.sub.1-4alkyl. 15. A compound according to claim 1 or a salt or phosphate ester thereof wherein R.sup.8 and R.sup.9 are independently hydrogen, halo, C.sub.1-4alkoxy, cyano, trifluoromethyl or phenyl. 16. A pharmaceutical composition comprising a compound of formula (I) as defined in claim 1, or a salt or phosphate ester thereof, in combination with a pharmaceutically acceptable carrier. 17. A method for treating colorectal or breast cancer in a warm blooded animal, in need of such treatment, which comprises administering to said animal an effective amount of a compound of formula (I), or a salt or phosphate ester thereof. 18. A method for preparing a compound of formula (I) as defined in claim 1 which method comprises reacting a compound of formula (II) ##STR00010## where X, R.sup.8 and R.sup.9 are as defined in claim 1, R.sup.1', R.sup.2', R.sup.3', R.sup.4' are groups R.sup.1, R.sup.2, R.sup.3, R.sup.4 as defined in claim 1 respectively; and R.sup.85 is a leaving group, with a compound of formula (III) ##STR00011## where R.sup.6 and R.sup.7 are as defined in claim 1 and R.sup.5' is a group R.sup.5 as defined in claim 1. 